Nano3D Biosciences, through its ChemoSen3D platform, offers a groundbreaking approach to cancer treatment by integrating proprietary cell-based functional assays with genetic testing. This innovative methodology aims to provide personalized treatment recommendations based on individual patient responses, thereby enhancing the precision of drug selection for cancer therapies. The ChemoSen3D technology utilizes a patented magnetic 3D bioprinting platform to create patient-derived spheroids for ex vivo testing of anti-cancer agents. This approach not only preserves the tissue heterogeneity critical for accurate drug response determination but also positions the technology as a vital component of pre-screening protocols alongside molecular testing.

The ChemoSen3D platform addresses significant challenges in cancer treatment, such as the ineffectiveness and toxicity of conventional therapies. By focusing on personalized chemosensitivity screening, the technology enables healthcare providers to identify the most effective treatments tailored to the unique biology of each patient's tumor. This data-driven approach enhances the likelihood of successful outcomes while minimizing the number of treatment rounds, ultimately improving patients' quality of life. The integration of phenotypical screening with genomic data further empowers physicians to make informed decisions, ensuring that treatment strategies are not only based on genetic profiles but also on how individual cancer cells respond to various drugs.

United States

Nano3D Biosciences (n3D) is a biotechnology startup located in Houston, TX focused on 3D cell culture solutions for biomedical research, drug discovery, toxicology, precision medicine, and regenerative medicine. Our core technology, magnetic 3D bioprinting, works by magnetizing cells and aggregating them with magnetic forces into models that represent native tissue environments. The advantages of this platform over other 3D cell culture and bioprinting platforms are speed, ease, and handling. n3D offers products and services around this technology, with a worldwide distribution network, including an OEM partnership with Greiner Bio-One

Nano3D Biosciences(ChemoSen3D)

Company Details